The Lung Cancer Centre of Excellence Conference 2017

Our second Lung Cancer Centre of Excellence Conference will bring together world experts across a range of disciplines to discuss the latest advances in lung cancer research and how we can continue to drive forward progress.

After decades of neglect, lung cancer research is finally coming out of the shadows. For a disease that researchers and clinicians once considered impenetrable, research is redefining our understanding of the disease, and is setting new standards of care. But we still face significant challenges.

By breaking down barriers between disciplines and by combining expertise we hope to open up new avenues for collaborative research in cancer cell biology, cutting edge drug discovery and novel approaches to the detection, monitoring and treatment of lung cancer.

Event Information

Sunday 3 – Tuesday 5 December 2017


The Midland Hotel, Manchester, UK, M60 2DS


From  £195

Abstract submission for posters closes on Friday 29 September 2017

The CRUK Lung Cancer Centre of Excellence

The CRUK Lung Cancer Centre of Excellence, based jointly between the University of Manchester and University College London, brings together the unique and complementary strengths of both partner organisations to create a collaborative environment in which integrated lung cancer research can flourish.

Find out more about the CRUK Lung Cancer Centre of Excellence

Contact us

If you need more information on the event please contact us:


If you are interested in sponsorship and exhibition opportunities, please contact

Freya Parry
Cancer Research UK
Tel +44 (0)203 469 8471

Sharon Vanloo
CRUK Lung Cancer Centre of Excellence
+44 (0)203 796 2940

Promotional pack

Use our posters, presentation slides and social media pictures to help spread the word about the conference to your colleagues.

Research opportunities in lung cancer

Lung Cancer

Survival for people with lung cancer remains low which is why we've made it a strategic priority. We have a broad range of funding opportunities for researchers wanting to focus on the disease.